Fouad Namouni, PRESIDENT, R & D at Blueprint Medicines Corp (BPMC), sold 7,266 shares at $89.32 ($649K) on 2024-10-03, disclosed to the SEC on 2024-10-04.
Seasonal sale ($649k) by PRESIDENT, R & D — this insider has traded BPMC in October in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $89.32 | 3,633 | $324K | 50.0% |
| 2 | $89.32 | 3,633 | $325K | 50.0% |
| Total | $89.32 avg | 7,266 | $649K | 100% |
| Filing → |
| BPMC | SELL | 2023-10-05 | $362K | — | Filing → |
| BPMC | SELL | 2023-03-08 | $175K | — | Filing → |
| BPMC | SELL | 2022-10-05 | $468K | — | Filing → |